Vascular endothelial growth factor (VEGF) and its receptors promote liver regeneration. The objective of the present study was to examine the role of VEGF receptor 1 (VEGFR1) signaling in hepatic tissue repair after acetaminophen (N-acetylpara-aminophenol) (APAP)-induced liver injury. To do this, we treated VEGFR1 tyrosine kinase knockout (VEGFR1 TK 2/2 ) and wild-type (WT) mice with APAP (300 mg/kg, ip). In WT mice, serum levels of alanine aminotransferase (ALT) and the necrotic area peaked between 8 and 24 h and then declined. In VEGFR1 TK 2/2 mice, ALT levels remained high at 48 h and extensive hepatic necrosis and hemorrhage were observed, as well as high mortality. Downregulation of hepatic messenger RNA expression of VEGFR1 and VEGFR2 was also noted in VEGFR1 TK 2/2 mice. VEGFR1 TK 2/2 mice displayed lower expression of proliferating cell nuclear antigen and of growth factors including hepatocyte growth factor, CD31, and basic fibroblast growth factor than WT. The hepatic microvasculature in VEGFR1 TK 2/2 was compromised as evidenced by impaired sinusoidal perfusion, suppressed endocytosis in liver sinusoidal endothelial cells (LSECs), and the formation of large gaps in LSECs. In WT mice, immunofluorescence revealed that recruited VEGFR1 1 cells in the necrotic area were positive for CD11b. VEGFR1 TK 2/2 exhibited fewer VEGFR1 1 and VEGFR2 1 cells. These results suggest that VEGFR1 signaling facilitates liver recovery from APAP hepatotoxicity by preventing excessive hemorrhage and reconstituting the sinusoids through recruitment of VEGFR1-expressing macrophages to the injured area and also through affecting expression of genes including hepatotrophic and pro-angiogenic growth factors.
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Acetaminophen (N-acetyl-para-aminophenol) (APAP) is a commonly used, over-the-counter analgesic and antipyretic with few side effects when taken at therapeutic doses. However, APAP toxicity from an overdose can result in severe hepatic damage characterized by hemorrhagic centrilobular necrosis and increased transaminase in both humans and animals (Mitchell et al., 1973) . The active APAP metabolite N-acetyl-p-benzquinone imine (NAPQI) is formed by metabolic activation of APAP by the cytochrome P-450 (CYP) family and plays a major role in APAP hepatotoxicity (Dahlin et al., 1984) . NAPQI initiates a series of intracellular events critical for hepatotoxicity, including glutathione (GSH) depletion and covalent cellular protein modification, resulting in oxidative stress, mitochondrial dysfunction, and DNA fragmentation (Jaeschke and Bajt, 2006) . These initial events are ultimately responsible for the opening of the mitochondrial membrane permeability transition pore (Kon et al., 2004) and cell death.
In addition to direct hepatocellular damage through metabolic activation of APAP, hepatic microcirculatory dysfunction also contributes to liver injury elicited by APAP overdose. APAPinduced hepatic necrosis is preceded by gap formation in liver sinusoidal endothelial cells (LSECs), leading to the penetration of blood elements into the space of Disse (Ito et al., 2003 (Ito et al., , 2005 Walker et al., 1983) . Impaired hepatic microcirculation and LSEC injury play key roles in the pathogenesis of APAP hepatotoxicity (DeLeve, 2007; McCuskey, 2008) .
Vascular endothelial growth factor (VEGF)-A is a major regulator of development and of physiological and pathological angiogenesis seen during tumorigenesis, inflammation, and wound healing Shibuya, 2008) . VEGF acts primarily through two tyrosine kinase receptors, VEGF receptor-1 (VEGFR1) (flt-1) and VEGFR2 (flk-1/kdr). VEGF-A binds to VEGFR1 with a 10-fold higher affinity than to VEGFR2, though the tyrosine kinase activity of VEGFR1 is relatively weak. VEGF-induced angiogenesis is mainly mediated by VEGFR2 activation Gille et al., 2001) . VEGFR2-null mutant mice die in the embryonic stage because of a lack of blood vessels, indicating that VEGFR2 signaling is essential for the development of vascular systems. By contrast, VEGFR1-null mutant mice die because of overgrowth and disorganization of blood vessels, suggesting that VEGFR1 is a negative regulator for angiogenesis during embryogenesis. Interestingly, however, mice expressing the VEGFR1 that lacks the tyrosine kinase domain develop generally healthy with normal blood vessels, suggesting that VEGFR1 kinase activity might not be required for vascular development during embryogenesis (Shibuya, 2008) , As a result, VEGFR1 was previously thought to be a nonsignaling ''decoy'' receptor; however, it has subsequently been shown that VEGFR1 signaling supports pathological angiogenesis under certain conditions such as tumor growth and tumor metastasis (Hiratsuka et al., 2001; Kaplan et al., 2005) .
During APAP-induced liver injury, VEGF and its receptors are upregulated, and treatment with a VEGFR2 inhibitor has been shown to impair hepatocyte proliferation following APAP exposure (Donahower et al., 2006) . Furthermore, hepatic tissue repair, including the reconstitution of hepatic microvasculature, plays a critical role in determining the final outcome of APAP hepatotoxicity (Mehendale, 2005) . However, the role of VEGFR1 receptor in APAP hepatotoxicity and repair of the hepatic sinusoids is not understood. The present study was thus conducted to examine whether VEGFR1 signaling is involved in liver injury and regeneration after APAP toxicity.
MATERIALS AND METHODS
Animals. Male C57BL/6J wild-type (WT) mice (8-10 weeks old) were purchased from CLEA Japan Inc. (Tokyo, Japan). VEGFR1 tyrosine kinase knockout (VEGFR1 TK À/À ) mice were developed and previously described by our group (Hiratsuka et al., 1998) . All animals were housed in an environmentally controlled room with a 12-h light/dark cycle and allowed free access to food and water. All animal experiments were approved by the Kitasato University School of Medicine and were performed in accordance with the Guidelines of Kitasato University School of Medicine for Animal and Recombinant DNA experiments.
Animal procedures. Animals were fasted overnight and then received 300 mg/kg APAP (Sigma-Aldrich, St Louis, MO) dissolved in warm saline (20 mg/ml) (ip).
Some animals were treated daily with oral gavage of ZD6474 (50 mg/kg) suspended in deionized water with 1% polysorbate 80 (Amano et al., 2003) . ZD6474 (AstraZeneca, Cheshire, UK) is a potent inhibitor of VEGFR2 tyrosine kinase activity (50% inhibitory concentration [IC 50 ], 40nM) but also has been shown to inhibit, with lower affinity, the kinase activity of VEGFR3 (IC 50 , 108nM) and epidermal growth factor receptor (IC 50 , 500nM) (Wedge et al., 2002) .
Experimental protocols. At the indicated time points, animals were anesthetized with pentobarbital sodium (50 mg/kg, ip). Blood was drawn from the heart and then centrifuged. Serum alanine aminotransferase (ALT) activity was measured by an automated procedure using an analyzer. Immediately after blood collection, the livers were excised and rinsed in saline. A small section from each liver was placed in 4% paraformaldehyde, and the remaining liver was frozen in liquid nitrogen and stored at À80°C.
Histology and immunohistochemistry. Excised liver tissues were immediately fixed with 4% paraformaldehyde in 0.1M sodium phosphate buffer (pH 7.4) for histological analysis (Katoh et al., 2010) . Sections (4 lm thick) were prepared from paraffin-embedded tissue and subjected to either hematoxylin and eosin staining or immunostaining. To quantify the extent of necrosis, the percentage of necrosis was estimated assessing the area of necrosis compared with the entire histological section. Analysis of area was performed with VH Analyzer (Keyence, Osaka, Japan). Concomitantly, the area occupied by extrasinusoidal erythrocytes was measured to quantify the extent of hemorrhage. The results were expressed as the percentage of hemorrhagic area. Sections were also stained for proliferating cell nuclear antigen (PCNA) (Invitrogen, Carlsbad, CA). PCNA incorporation was measured at 48 h after APAP treatment. Each treatment group included six mice per time point. PCNA þ hepatocytes were counted in eight separate low-power fields for each animal, and the average number of PCNA þ cells was calculated.
Immunofluorescent staining. Samples were fixed with periodate-lysineparaformaldehyde fixative at room temperature for 3 h. Following cryoprotection with 30% sucrose/0.1M phosphate buffer (pH 7.2), cryostat sections approximately 10-to 20-lm thick were cut, and nonspecific staining was blocked by incubation with 1% bovine serum albumin/PBS for 1 h. The sections were incubated at room temperature for 1 h with the following primary antibodies: rabbit anti-mouse CD31 polyclonal immunoglobulin G (IgG) antibody (Abcam, CB, UK), rat anti-mouse F4/80 monoclonal IgG 2a antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA), rabbit anti-mouse VEGFR1 polyclonal IgG antibody (Santa Cruz Biotechnology Inc.), rat anti-mouse VEGFR2 monoclonal IgG 2a antibody (BD Pharmingen, San Jose, CA), rabbit anti-mouse lymphatic vessel endothelial hyaluronan receptor 1 (Lyve-1) polyclonal IgG antibody (Abcam), and rat anti-mouse CD11b monoclonal IgG 2b antibody (BD Pharmingen). After washing three times in PBS, the sections were incubated with a mixture of secondary antibodies for 1 h at room temperature. Negative control staining was conducted by replacing the primary antibodies with control IgG for each immune animal. The secondary antibodies used were Alexa Fluor 488-or 594-conjugated donkey anti-rabbit and rat IgGs purchased from Molecular Probes, Inc. (Eugene, OR). Sections were then observed using a confocal scanning laser microscope (LSM710: Carl Zeiss MicroImaging GmbH, Oberkochen, Germany).
After double labeling, eight low-power optical fields were randomly selected, and the number of positive cells was counted for every single channel as well as the merged channels for each animal. Three animals were analyzed for each marker analysis.
Real-time RT-PCR analysis. Each sample of excised tissue was immediately immersed in TRIzol reagent (Invitrogen) and homogenized. Total RNA was extracted from homogenized tissue and measured using a BioPhotometer (Eppendorf Co. Ltd, Tokyo, Japan). Single-stranded complementary DNA was reverse transcribed from 1 lg of total RNA using a ReverTra Ace qPCR RT kit (TOYOBO Co., Ltd, Osaka, Japan), according to the manufacturer's instructions. qPCR amplification was performed using SYBR Premix Ex Taq (Takara Bio Inc., Shiga, Japan). The gene-specific primers used are described in Supplementary table 1S. PCR was performed in 20-ll reactions according to the manufacturer's protocol. The reaction mixture was then subjected to 40 cycles of amplification in a DNA thermal cycler. Each cycle consisted of a heatdenaturation step at 95°C for 1 min, a primer annealing step at 55°C for 1 min, and an extension step at 72°C for 1 min. After completion of 40 PCR cycles, the samples were incubated at 72°C for 5 min. Data were normalized to the expression level of glyceraldehyde-3-phosphate dehydrogenase in each sample.
ELISA and GSH/GSSG assay. Organs were removed and snap frozen in liquid nitrogen. Frozen tissues were homogenized in Tissue Extraction Reagent I (Invitrogen) and 0.05% protease inhibitor cocktail (Sigma-Aldrich) and were centrifuged to separate the supernatant. Mouse VEGF and pro-matrix metalloproteinase (MMP)-9 were measured using a Quantikine ELISA kit (R&D Systems, Minneapolis, MN). Hepatic GSH and oxidized glutathione (GSSG) were measured colorimetrically with a BIOXYTECH GSH/GSSG Assay kit (OxisRiresearch, Portland, OR).
In vivo microscopy. Animals were anesthetized with pentobarbital sodium (50 mg/kg, ip), and tissues were prepared for in vivo fluorescence microscopy as previously described (Katagiri et al., 2004) . The hepatic microcirculation was observed using a fluorescence microscope (ECLIPSE E600, upright type;
Nikon, Tokyo, Japan) with a 100-W mercury lamp for epi-illumination. The microscopic images were obtained with a long working distance objective lens (M plan 20/0.35 super long working distance; Nikon) and an X10 eyepiece lens. Images of the microcirculation were transmitted through a CCD camera (C7190; Hamamatsu Photonics; Hamamatsu) to a monitor and were recorded for subsequent offline analysis. Mice were injected iv with 50 ll of acetylated low-density lipoprotein (Ac-LDL) (1:2 dilution in PBS; Invitrogen) immediately prior to liver sinusoidal visualization. Microvascular events were observed and recorded. The relative adequacy of blood perfusion through the sinusoids was evaluated by counting the number of sinusoids exhibiting blood flow in 10 regions in each animal. The number of perfused sinusoids was expressed as a percentage of total sinusoids regardless of blood flow per region.
Electron microscopy. For electron microscopy, livers were perfused through the portal vein with PBS and fixed with 2.5% glutaraldehyde and prepared for scanning electron microscopy (SEM) (Ito et al., 2006) . Tissues were visualized on a JEM-6360 SEM (JEOL, Peabody, MA).
Statistics. All results are expressed as means ± SDs. All statistical analyses were performed using GraphPad Prism version 5.01 (GraphPad Software, La Jolla, CA). Student's t-test was used for comparison of two groups. Comparisons between multiple groups were performed using one-way ANOVA followed by Bonferroni's post hoc test. If the data were not normally distributed as a result of Bartlett's test, we used the Kruskal-Wallis test (nonparametric ANOVA) followed by Dunn's multiple comparisons test. Survival experiments were analyzed using the log-rank test and presented as Kaplan-Meier survival curves. Statistical significance compared with WT or untreated mice is indicated as follows: * or †, p < 0.05; ** or † †, p < 0.01; and *** or † † †, p < 0.001.
RESULTS

Aggravated Liver Injury in VEGFR1 TK À/À Mice after APAP Treatment
To examine whether VEGFR signaling affects liver injury elicited by APAP, APAP was administered to WT mice, VEGFR1 TK À/À mice, and WT mice treated with ZD6474, a potent inhibitor of VEGFR2 kinase activity. Serum ALT levels in WT mice peaked 8 h after APAP administration and had declined markedly by 48 h (Fig. 1A) . ALT had returned to baseline levels at 76 and 96 h after APAP administration. ZD6474-treated mice showed similar results to WT mice. By contrast, ALT levels in VEGFR1 TK À/À mice were also maximal at 8 h but remained high at 48 h after APAP administration. Histological evaluation of the liver revealed that the area of necrosis was similar among the three groups at 24 h after APAP administration (Fig. 1B) . The size of the necrotic area was reduced at 48 h and declined thereafter in WT and ZD6474-treated WT mice. By contrast, extensive necrosis still remained at 48 h in VEGFR1 TK À/À mice. In addition, substantial hemorrhagic necrosis was observed in VEGFR1 TK À/À mice, but not in WT or ZD6474-treated mice (Fig. 1C) . Indeed, quantitative analysis revealed that hemorrhage in WT mice was observed at 8 h, and the region was marginally increased at 24 h and decreased by 48 h (Supplementary fig.  1S ). In VEGFR1 TK À/À mice, hemorrhage was evident at 4 h, and the area was further increased up to 48 h. There was a significant difference at 24 and 48 h between VEGFR1 TK À/À and WT mice. The survival rate was also substantially lower in VEGFR1 TK À/À mice (19%) than in WT (100%) or ZD6474-treated WT (89%) mice (Fig. 1D) .
VEGFR Signaling Does Not Affect Hepatic CYP2E1 or GSH
To rule out the possibility that aggravated liver injury in VEGFR1 TK À/À mice resulted from an altered capacity to metabolically activate APAP, we examined the time course of hepatic CYP2E1 and GSH messenger RNA (mRNA) expression. Hepatic expression of CYP2E1, which is involved in APAP bioactivation, did not differ significantly among the three groups (Fig. 1E) . Decreased hepatic GSH is a widely accepted indicator of the generation of the reactive intermediate. The administration of APAP caused an 80% depletion of hepatic GSH levels within 1 h. However, no differences in basal GSH levels or depletion after APAP treatment were observed among the three groups (Fig. 1F) . The same was true for GSSG levels and the GSH/GSSG ratio. These results suggest that all three groups had a similar capacity to metabolically activate APAP and that impaired VEGFR signaling does not affect APAP metabolism.
Taken together, these results indicate that VEGFR1, not but VEGFR2, is involved in liver injury and repair following APAP toxicity. Based on these findings, we compared WT mice and VEGFR1 TK À/À mice in subsequent experiments. In addition, because many VEGFR1 TK À/À mice died accompanied by severe hemorrhage within 72 h after APAP treatment, we decreased the length of time course of subsequent experiments to 48 h after APAP treatment.
VEGF/VEGFR Expression in the Liver after APAP Administration
Because VEGFR1 signaling appears to contribute to APAPinduced liver injury (Fig. 1) , we examined the hepatic expression profile of VEGF/VEGFRs induced by APAP administration. VEGF-A mRNA expression was maximal at 4 and 8 h in the livers of WT and VEGFR1 TK À/À mice, respectively, after APAP treatment ( Fig. 2A) . Hepatic VEGF protein gradually increased over 48 h in both of WT and VEGFR1 TK À/À mice (Fig. 2B) . However, there was no difference in VEGF expression between the two groups. VEGFR1 mRNA was significantly increased in the livers of WT mice at 4 and 8 h after APAP treatment and returned to basal levels thereafter (Fig. 2C) . VEGFR1 mRNA was lower in VEGFR1 TK À/À mice than in WT mice from 4 to 24 h after APAP administration. VEGFR2 mRNA expression did not change significantly in WT mice over the time course but decreased over time after APAP treatment in VEGFR1 TK À/À mice (Fig. 2D ). VEGFR2 mRNA was significantly lower in VEGFR1 TK À/À mice than in WT mice 48 h after APAP administration. that the liver enters a proliferative phase. Timely onset of tissue repair processes can limit liver injury and promote regeneration of lost tissue mass (Mehendale, 2005) . To determine whether differences in hepatocyte proliferation between WT and VEGFR1 TK À/À mice might account for the differences observed in liver injury and mortality, hepatocyte proliferation was assessed by PCNA staining 48 h after APAP administration (Fig. 3A) . At 48 h, substantial PCNA staining was observed in hepatocytes surrounding the necrotic areas in WT mice, but not in VEGFR1 TK À/À mice (Fig. 3A) . The number of PCNA þ hepatocytes 48 h after was increased (98-fold) in WT mice when compared with untreated animals, whereas very few positive cells were identified in VEGFR1 TK À/À mice (Fig. 3B) .
Suppressed Liver Regeneration in VEGFR1 TK
Because inflammatory cytokines such as hepatocyte growth factor (HGF), tumor necrosis factor alpha (TNF-a), and interleukin (IL) 6 play a critical role in initiation of liver regeneration, we also measured expression of these growth factors using real-time RT-PCR (Fig. 3C) . The levels of hepatic HGF and TNF-a mRNA expression 48 h after APAP treatment in WT mice were increased to 2.3-fold and 3.4-fold, respectively, as compared with untreated controls, whereas IL-6 mRNA was decreased by 63%. Hepatic HGF and TNF-a mRNA expression were higher in WT mice than in VEGFR1 TK À/À mice after APAP treatment, whereas upregulation of IL-6 after APAP was observed only in VEGFR1 TK À/À mice.
Alterations in Hepatic Microcirculature
Evidence suggests that in addition to hepatocyte damage, APAP overdose can also cause LSEC injury, leading to hepatic microcirculatory dysfunction (Ito et al., 2003) . This suggests that sinusoidal restoration may be an important process in liver repair. Previous results have shown that penetration of red blood cells into the space of Disse, namely, hemorrhage, and impaired sinusoidal perfusion peaked at 6 h and attenuated at 12 h (Ito et al., 2003; McCuskey, 2008) , suggesting that the sinusoids were under the process 24 h after APAP hepatotoxicity. Based on these findings, we selected the time point at 24 h to investigate the sinusoidal restoration, and we directly observed liver microcirculation during APAP hepatotoxicity. At 24 h after APAP treatment, sinusoidal perfusion in WT mice was restored to 96% of that in the untreated controls (Fig. 4A) . By contrast, liver microcirculation was decreased by 40% in VEGFR1 TK À/À mice. To examine the functional integrity of LSECs, we assessed the ability of these cells to endocytose ligands. To do this, we administered fluorescently labeled Ac-LDL to mice 24 h after APAP treatment (Fig. 4B) . Ac-LDL uptake by scavenger receptors on LSECs was slightly suppressed in the centrilobular sinusoids of APAPtreated WT mice compared with untreated controls. By contrast, few endothelial cells with incorporated Ac-LDL were observed in VEGFR1 TK À/À mice, and the microvasculature was difficult to visualize. These results suggest that VEGFR1 signaling plays a role in the restoration of liver Although Ac-LDL is endocytosed through scavenger receptors predominantly expressed on LSECs, Kupffer cells also participate in Ac-LDL endocytosis (Nagelkerke et al., 1983) , indicating that Ac-LDL is not a specific marker for LSECs. Therefore, we also examined the sinusoids using immunofluorescent labeling of an antibody against Lyve-1, another member of the scavenger receptor family that is expressed on LSECs and absent on other hepatic cells (Mouta Carreira et al., 2001) (Supplementary fig. 2S ). Immunoreactivity with Lyve-1 was suppressed in VEGFR1 TK À/À mice compared with WT mice, which was consistent with the results of our intravital microscopy study.
SEM examination was conducted to investigate ultrastructural changes in LSECs 24 h after APAP treatment. Livers of untreated control mice demonstrated intact LSECs with fenestrations organized in sieve plates (Fig. 4C) . By contrast, livers of VEGFR1 TK À/À mice showed significant damage with formation of very large gaps in LSECs. In WT mice, the sinusoid lining was nearly restored, but a loss of fenestration was observed. A similar reduction in porosity has been observed in regenerating LSECs after partial hepatectomy and liver transplantation (Stolz et al., 2007) .
We also measured hepatic MMP-9 mRNA and protein after APAP treatment (Fig. 4D) because it has been suggested that the gap formation in LSECs is caused by MMP activation (DeLeve, 2007; Ito et al., 2005) . Both of WT and VEGFR1 TK À/À mice exhibited enhanced hepatic levels of MMP-9 expression following APAP hepatotoxicity as compared with basal levels. Hepatic MMP-9 expression was significantly increased in VEGFR1 TK À/À mice.
Pro-angiogenic Factors after APAP Treatment
Because VEGF/VEGFRs are upregulated and VEGFR1 is involved in sinusoidal reconstitution following APAP hepatotoxicity, we also analyzed expression of pro-angiogenic growth factors 48 h after APAP treatment. In WT mice, hepatic mRNA expression of CD31, basic fibroblast growth factor (bFGF), and transforming growth factor (TGF) b was increased to 2.9-fold, 6.3-fold, and 3.1-fold, respectively, as compared with basal levels. On the other hand, VEGFR1 TK À/À mice displayed downregulation of CD31 expression (27% reduction) and no changes in bFGF and TGFb expression. Hepatic mRNA expression of bFGF and TGFb was reduced in VEGFR1 TK À/À mice relative to WT mice (Fig. 4E) . Expression of the endothelial marker CD31 was also reduced in VEGFR1 TK À/À mice. These results suggest that VEGFR1 is crucial for sinusoid restoration after APAP-induced liver injury.
Immunofluorescence
To assess the localization of VEGFR1 expression in the liver after treatment with APAP, we performed immunofluorescent staining analysis.
Treatment of WT mice with APAP for 48 h caused accumulation of VEGFR1 þ cells in the centrilobular region (1.7-fold increase) when compared with untreated controls (Figs. 5A, 5C , 5K, 5M, 6A, and 6D). By contrast, very few accumulated VEGFR1 þ cells were found in VEGFR1 (Figs. 6A  and 6D ). It has been reported that VEGFR1 is expressed in both endothelial cells and macrophages (Shibuya, 2008) . To identify the sinusoidal cells expressing VEGFR1, liver sections were stained with CD31 or F4/80. In controls, CD31 was expressed only on the portal and central veins and not on the sinusoids (data not shown). Treatment with APAP for 48 h induced expression of CD31 on the portal and central veins, with scattered expression in the centrilobular sinusoids (Supplementary fig. 3S ); however, no colocalization of VEGFR1 and CD31 was observed. These results suggest that VEGFR1-expressing cells do not express CD31. Treatment of WT mice with APAP caused no change in the numbers of F4/80 þ cells in the periportal region but an 89% decrease in the centrilobular region (Figs. 5A, 5E , and 6B). Double labeling assay of VEGFR1 and F4/80 revealed that 59% of VEGFR1 þ cells in the periportal region were positive for F4/80, whereas only 2% of VEGFR1 þ cells in the centrilobular region were positive (Figs. 5G, 5I, and 6C) . This is consistent with a previous report that APAP administration reduces the accumulation of F4/80 þ cells in the centrilobular region (Laskin et al., 1995) . Thus, we applied another macrophage marker, CD11b, which is thought to be derived from bone marrow or circulating monocytes (Holt et al., 2008) . In controls, few CD11b þ cells were found in both of WT and VEGFR1 TK À/À mice (Figs. 5K, 5L, and 6E). In WT mice, APAP treatment caused a significant increase (27-fold) in CD11b þ cells in the centrilobular region as compared with untreated controls (Figs. 5O and 6E ). By contrast, in mice, CD11b was moderately increased to 4.8-fold (Figs. 5P and 6E ). About 54% of accumulated VEGFR1 þ cells in the injured region were positive for CD11b (Figs. 5Q, 5S , and 6F), suggesting that VEGFR1 þ cells in the injured region are recruited macrophages and not resident macrophages. The number of VEGFR1 þ /CD11b þ cells infiltrating into the necrotic area in VEGFR1 TK À/À mice was reduced by 87% as compared with WT mice (Figs. 5Q, 5R , and 6F). These results suggest that VEGFR1 TK signaling plays a role in the recruitment of VEGFR1 þ /CD11b þ cells in the livers of mice treated with APAP.
As depicted in Supplementary figure 4S, VEGFR2 was expressed in the sinusoids of WT mice 48 h after APAP treatment (Supplementary figs. 4S-A and 4S-G), while reduced expression of VEGFR2 was seen in VEGFR1 TK À/À mice (Supplementary figs. 4S-D and 4S-J). Because it has been reported that VEGFR2 is expressed on endothelial cells (Shibuya, 2008) , double immunofluorescence analysis was performed to determine which cells expressed VEGFR2 in the liver. VEGFR2 was expressed along the sinusoids, and VEGFR2 þ cells were positive for CD31 (Supplementary fig.  4S -C) and Lyve-1 (Supplementary fig. 4S-I) . These results suggest that the VEGFR2-expressing cells were endothelial cells.
þ and Lyve-1 þ was attenuated in VEGFR1 TK À/À mice (Supplementary figs. 4S-F and 4S-L). These results indicate that VEGFR1 TK signaling is responsible for recruitment of VEGFR2 þ cells to the injured region after APAP toxicity.
DISCUSSION
The hepatic microvasculature is an early target in APAP injury (DeLeve et al., 1997; Ito et al., 2003; McCuskey, 2008) . During the early phase of APAP hepatotoxicity, the formation of gaps in LSECs precedes hepatic parenchymal injury (Ito et al., 2003) . These gaps in the cytoplasm are formed by the destruction and/or coalescence of fenestrae, which permit red blood cells to penetrate into the space of Disse. Subsequently, the sinusoid may collapse or disintegrate, reducing blood flow by 30% within 6 h after APAP treatment. Endocytosis of LSECs mediated by the hyaluranon scavenger receptor is depressed from 2 to 12 h after injury. MMPs and nitric oxide have also been shown to be involved in LSEC injury and hepatic microcirculatory dysfunction (DeLeve, 2007; Ito et al., 2004 Ito et al., , 2005 . The current study revealed that hemorrhage was taken place earlier in VEGFR1 TK À/À mice than in WT mice, suggesting that VEGFR1 TK signaling is preventive from early LSEC injury. Although hepatic microvascular injury by APAP has been demonstrated, the process of sinusoidal restoration following such injury is not yet fully understood. The present study demonstrated that hemorrhage was resolved in WT mice by 48 h after APAP administration, whereas extensive hemorrhage and necrosis were evident in VEGFR1 TK À/À mice. In addition, sinusoidal perfusion was restored in WT mice, whereas a 40% reduction in liver microcirculation was demonstrated in VEGFR1 TK À/À mice. SEM studies revealed the formation of large gaps in the endothelium of VEGFR1 TK À/À mice, whereas in WT mice, few gaps were formed, but a reduction in fenestration and porosity was seen in LSECs. The large gap formation in LSECs and impaired sinusoidal perfusion in VEGFR1 TK À/À mice were associated with enhanced hepatic MMP-9 expression, suggesting that MMP-9 activation results in injured hepatic microvasculature in VEGFR1 TK À/À mice. The absence of VEGFR1 TK gene expression in VEGFR1 TK À/À mice reduced endocytosis along the hepatic sinusoids and decreased uptake of Ac-LDL, whereas endocytotic activity was restored after injury in WT mice. A massive accumulation of blood in the space of Disse in VEGFR1 TK À/À mice impaired the liver microcirculation and reduced oxygen supply to hepatocytes. These findings indicate that VEGFR1 TK signaling is required to initiate sinusoidal restoration and to maintain the integrity of the hepatic sinusoids.
During acute liver injury elicited by APAP, the expression of VEGF and its receptors is enhanced (Donahower et al., 2006; Papastefanou et al., 2007) . In the present study, VEGF protein VEGFR1 FACILITATES LIVER REGENERATION 225 levels are elevated over 48 h after APAP administration, and VEGFR1 mRNA is enhanced 4 and 8 h, whereas VEGFR2 mRNA did not change within 48 h. On the other hand, using rat APAP hepatotoxicity model, Papastefanou et al. (2007) have shown that the levels of VEGF and VEGFR2 are increased with a three-peak pattern at 12-24, 72-96, and 192-240 h, whereas VEGFR1 is upregulated at 24 h. Each time point of significant expression levels during the course of APAP hepatotoxicity is corresponded to the initial inflammatory process, hepatocyte regeneration process, and remodeling process, respectively. Although the discrepancy may be attributed to differences in interspecies, the dosage of APAP or the mode of administration, and experimental observation periods, these findings indicate the importance of VEGF/VEGFRs in liver regeneration after APAP toxicity. VEGFR1 TK À/À mice develop a normal vascular system but display a defect in the migration of macrophages (Hiratsuka et al., 1998) . By contrast, when the transmembrane (TM) domain of VEGFR1 is further deleted from VEGFR1 TK À/À mice, half of VEGFR1 TM-TK À/À mice die as embryos with disorganization of vessels (Hiratsuka et al., 2005) . In addition, they have suggested that the TM domain of VEGFR1 is important for angiogenesis by trapping VEGF for the appropriate regulation of VEGFR2 signaling. Thus, the phenotype of VEGFR1 TK À/À mice is different from VEGFR1 (TM-TK) À/À mice. Here, we focused on the role of VEGFR1 TK signaling in the recruitment of macrophages during APAP hepatotoxicity. Double-staining analysis revealed that VEGFR1 þ cells were positive for CD11b, but not F4/80. Recent reports have revealed that macrophages accumulated in response to an APAP challenge represent a bone marrowderived circulating monocyte/macrophage population, distinct from resident Kupffer cells (Holt et al., 2008) . Indeed, it has been shown that VEGFR1 is expressed not only on vascular endothelial cells but also on monocytes/macrophages (Clauss et al., 1996) . VEGFR1 signaling is involved in the VEGFdependent migration of macrophages, which secrete various angiogenic factors (Hiratsuka et al., 1998; Sawano et al., 2001) . The recruitment of macrophages into the ear skin is facilitated in VEGF-A transgenic mice and is decreased in VEGFR1 TK À/À mice (Murakami et al., 2008) . VEGFR1 TK À/À mice also display reduced infiltration of monocytes/ macrophages into arthritic joints of rheumatoid arthritis model (Murakami et al., 2006) . These findings indicate that macrophages recruited by VEGF-A through VEGFR1 TK signaling appear to be closely related to local inflammation (Shibuya, 2008) . Therefore, it is conceivable that the infiltration of macrophages into the liver during APAP intoxication was less extensive in VEGFR1 TK À/À mice than in WT mice. In addition, it has been previously shown that VEGFR1 TK À/À mice exhibit reduced angiogenesis in parallel with decreased recruitment of VEGFR1-expressing macrophages (Murakami et al., 2008) . Based on reports of the role of macrophages in tissue repair following APAP liver injury (Holt et al., 2008) , it is possible that VEGFR1/CD11b may play a key role in this tissue repair process. Taken together, these findings imply that the VEGFR1 signaling pathway contributes to the recruitment of macrophages, which promote reconstitution of damaged sinusoids after APAP toxicity.
Our experiments suggest that VEGFR1 TK signaling during APAP hepatotoxicity affects the gene expression in the liver. Abrogation of VEGFR1 TK signaling resulted in downregulated expression of VEGFR2 in the liver. Because VEGFR2 activation is important for the promotion of angiogenesis Gille et al., 2001) , blunted expression of VEGFR2 in VEGFR1 TK À/À mice could impair regeneration-associated angiogenesis. Indeed, expression of several pro-angiogenic growth factors, including bFGF and TGFb, was suppressed in VEGFR1 TK À/À mice. Although the induction of TGFb after APAP administration has been shown, its role in liver regeneration after APAP toxicity remains to be elucidated (Tygstrup et al., 1997) . APAP also elicited expression of CD31 mRNA in the liver and of CD31 protein in the centrilobular sinusoids. These results imply the sinusoidal capillarization, which is consistent with the pathological defenestration in LSECs (DeLeve et al., 2004) as gauzed by SEM. Expression of the endothelial marker CD31 was also reduced in VEGFR1 TK À/À mice, suggesting that the integrity of LSECs is compromised, which leads to larger gap formation in LSECs and hemorrhage. Thus, VEGFR1 TK signaling exerts a protective action against LSEC injury elicited by APAP.
Cellular cross talk between LSECs and hepatocytes plays an important role in sinusoidal homeostasis and physiological angiogenesis during liver regeneration (Fernández et al., 2009) . Differential signaling of VEGF through its receptors highlights the intricacy of this communication system in the liver. During liver regeneration following partial hepatectomy, upregulation of VEGF and its receptors is important for proliferation of LSECs (Ross et al., 2001) . In liver regeneration following carbon tetrachloride toxicity, VEGFR1 activation elicits paracrine release of tissue-specific growth factors (HGF and IL-6) from LSECs, resulting in the proliferation of hepatocytes, and signaling through VEGFR2 stimulates LSEC proliferation . In the current study, sinusoidal restoration following APAP treatment was accompanied by the initiation of hepatocyte proliferation and enhanced expression of growth factors such as HGF and TNF-a. Because HGF is a potent mitogen of hepatocytes as well as a pro-angiogenic factor, HGF would contribute to liver regeneration after APAP toxicity as demonstrated in the model of carbon tetrachloride toxicity . VEGFR1 TK À/À mice showed sustained hepatic necrosis and decreased hepatocyte proliferation, suggesting that the VEGF/VEGFR1 signaling pathway participates in tissue repair through enhancement of HGF and TNF-a, although the mechanisms of the effects of VEGFR1 signaling on hepatocyte proliferation remain to be clarified.
IL-6 plays a critical role in liver regeneration and hepatoprotection in a variety of liver injury as well as resection models. During APAP hepatotoxicity, IL-6 expression is enhanced and IL-6 À/À mice exhibit delayed hepatocyte regeneration as indicated by reduced hepatic expression of PCNA (James et al., 2003) . However, we showed that PCNA expression was upregulated but IL-6 expression was downregulated in WT mice. These results indicate that liver regeneration is independent of IL-6. Consistent with this, treatment with IL-6 fails to promote PCNA expression and had no effect on liver injury during APAP toxicity (Bajt et al., 2003; James et al., 2003) . In addition, we demonstrated that VEGFR1 TK À/À mice exhibited aggravated liver injury with suppressed PCNA expression but enhanced IL-6 expression. Furthermore, Donahower et al. (2010) have shown that the administration of human recombinant VEGF to mice treated with APAP minimizes liver injury with facilitated PCNA expression but also attenuates IL-6 and enhances VEGFR1. These observations suggest a possible redundancy between VEGFR1 and IL-6 in exacerbation of hepatic inflammation or in promotion of liver regeneration and the tissue repair process.
VEGFR2 is known to be the critical growth factor receptor for angiogenesis and endothelial cell proliferation. The current study showed that pharmacological manipulation of VEGFR2 kinase inhibition did not affect hepatocellular injury by APAP or the sinusoidal tissue repair process. However, another study found that VEGFR2 inhibition delayed resolution of liver injury from APAP toxicity and suppressed hepatocyte proliferation as indicated by reduced PCNA expression in the liver after APAP treatment (Donahower et al., 2006) . The discrepancy between that study and the present study may be attributable to differences in compounds and animal species used.
In conclusion, VEGFR1 TK signaling is responsible for liver repair and sinusoidal restoration after APAP hepatotoxicity through recruitment of VEGFR1-expressing macrophages to the injured regions and through enhancement of transcripts including hepatic and pro-angiogenic growth factors. Targeting VEGFR1 TK activity could affect sinusoidal integrity and hepatocyte proliferation following acute liver injury. Thus, selective activation of VEGFR1 appears to promote sinusoidal restoration after acute liver injury, thereby facilitating tissue repair.
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